We are live on ! Find out more
SCA

STALEY CAPITAL ADVISERS Portfolio holdings

AUM $2.57B
1-Year Est. Return 26.96%
This Fund
S&P 500
This Quarter Est. Return
+3.29%
1 Year Est. Return
+26.96%
3 Year Est. Return
+81.86%
5 Year Est. Return
+86.55%
10 Year Est. Return
+309.61%
AUM
$2.17B
AUM Growth
+$31.6M
Cap. Flow
-$21.2M
Cap. Flow %
-0.98%
Top 10 Hldgs %
48.47%
Holding
188
New
5
Increased
37
Reduced
50
Closed
6

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$72.2M
2
QCOM icon
Qualcomm
QCOM
+$5.98M
3
NVDA icon
NVIDIA
NVDA
+$4.85M
4
PM icon
Philip Morris
PM
+$2.85M
5
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$2.58M

Sector Composition

Rank Sector Weight
1 Technology 25.15%
2 Miscellaneous 21.97%
3 Financials 10.39%
4 Consumer Discretionary 8.57%
5 Communication Services 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANIX icon
176
Anixa Biosciences
ANIX
$90.4M
$22.1K ﹤0.01%
10,000
KOPN icon
177
Kopin
KOPN
$807M
$15.1K ﹤0.01%
18,000
BIL icon
178
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$47B
-6,200
Closed -$569K
BSV icon
179
Vanguard Short-Term Bond ETF
BSV
$46.1B
-2,742
Closed -$210K
CVS icon
180
CVS Health
CVS
$117B
-905,366
Closed -$72.2M
FBIN icon
181
Fortune Brands Innovations
FBIN
$4.72B
-2,530
Closed -$214K
PPG icon
182
PPG Industries
PPG
$23.3B
-1,568
Closed -$227K

Similar funds

STALEY CAPITAL ADVISERS's Q2 2024 Portfolio in Review

As of Q2 2024, STALEY CAPITAL ADVISERS held 188 positions worth $2.17B, up 1.5% from $2.14B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

STALEY CAPITAL ADVISERS's Q2 2024 filing shows 5 new, 37 increased, 50 reduced and 6 closed positions. Its largest new stake was J.M. Smucker: 499,125 shares worth $54.4M. The largest sale was CVS Health, an estimated $72.2M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Miscellaneous and Financials.

  • STALEY CAPITAL ADVISERS's largest Q2 2024 buy was J.M. Smucker: 499,125 shares worth $54.4M.
  • STALEY CAPITAL ADVISERS added most to Pfizer in Q2 2024, an estimated $16.3M increase.
  • STALEY CAPITAL ADVISERS's biggest Q2 2024 reduction was Qualcomm, cutting an estimated $5.98M.
  • STALEY CAPITAL ADVISERS fully exited CVS Health in Q2 2024, selling an estimated $72.2M.
  • STALEY CAPITAL ADVISERS's ten largest holdings make up 48% of its $2.17B portfolio in Q2 2024.
  • STALEY CAPITAL ADVISERS opened 5 new positions and closed 6 in Q2 2024.
  • STALEY CAPITAL ADVISERS's portfolio value rose 1.5% quarter-over-quarter to $2.17B.

Based on STALEY CAPITAL ADVISERS's 13F filing for Q2 2024, filed 13 Aug 2024.